Dose dependent separation of the hypertrophic and myotoxic effects of the β2 agonist clenbuterol in rat striated muscles

Muscle and Nerve

Volumn 33, Issue 5, 2006, Pages 655-663

  Burniston, Jatin G ^a   Clark, William A ^b   Tan, Lip Bun ^c   Goldspink, David F ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b MICHAEL REESE HOSPITAL   (United States)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Apoptosis; Collagen; Heart muscle; Hypertrophy; Necrosis; Skeletal muscle

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; COLLAGEN; MUSCLE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DIAPHRAGM; DOSE RESPONSE; DRUG INFUSION; DRUG SAFETY; MALE; MUSCLE CELL; MUSCLE GROWTH; MUSCLE HYPERTROPHY; NONHUMAN; PLANTARIS MUSCLE; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE;

ADRENERGIC BETA-AGONISTS; ANIMALS; APOPTOSIS; CLENBUTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTROPHY; MALE; MUSCLE FIBERS; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOCARDIUM; NECROSIS; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 33646244955     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20504     Document Type: Article

References (41)

1. Bakker AJ, Head SI, Wareham AC, Stephenson DG. Effect of clenbuterol on sarcoplasmic reticulum function in single skinned mammalian skeletal muscle fibres. Am J Physiol 1998;274:C1718-C1726.
2. Barki-Harrington L, Perrino C, Rockman HA. Network integration of the adrenergic system in cardiac hypertrophy. Cardiovasc Res 2004;63:391-402.
3. Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 1989;65:657-670.
4. 2- adrenergic receptor agonist, clenbuterol. Muscle Nerve 2005;32:767-774.
5. Burniston JG, Ng Y, Clark WA, Colyer J, Tan L-B, Goldspink DF. Myotoxic effects of clenbuterol in the rat heart and soleus muscle. J Appl Physiol 2002;93:1824-1832.
6. 2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle. J Appl Physiol 2005;98:1379-1386.
7. Busquets S, Figueras MT, Fuster G, Almendro V, Moore-Carrasco R, Ametiller E, et al. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. Cancer Res 2004;64:6725-6731.
8. Chen KD, Alway SE. A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats. J Appl Physiol 2000;89:606-612.
9. Chen KD, Alway SE. Clenbuterol reduces soleus muscle fatigue during disuse in aged rats. Muscle Nerve 2001;24:211-222.
10. Choo JJ, Horan MA, Little RA, Rothwell NJ. Anabolic effects of clenbuterol in skeletal muscle are mediated by beta2-adrenoceptor activation. Am J Physiol 1992;263:E50-E56.
11. Criswell DS, Powers SK, Herb RA. Clenbuterol-induced fibre type transition in the soleus of adult rats. Eur J Appl Physiol 1996;74:391-396.
12. Dodd SL, Powers SK, Vrabas IS, Criswell D, Stetson S, Hussain R. Effects of clenbuterol on the contractile and biochemical properties of skeletal muscle. Med Sei Sport Exerc 1996;28:669-676.
13. Duncan ND, Williams DA, Lynch GS. Deleterious effects of chronic clenbuterol treatment on endurance and sprint exercise performance in rats. Clin Sci 2000;98:339-347.
14. Emery PW, Rothwell NJ, Stock MJ, Winter PD. Chronic effects of beta2-adrenergic agonists on body composition and protein synthesis in the rat. Biosci Rep 1984;4:83-91.
15. Goldspink DF, Burniston JG, Ellison GM, Clark WA, Tan LB. Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways? Exp Physiol 2004;89:407-416.
16. Gregorevic P, Ryall JG, Plant DR, Sillence MN, Lynch GS. Chronic beta-agonist administration affects cardiac function of adult but not old rats, independent of beta-adrenoceptor density. Am J Physiol 2005;289:H344-H349.
17. Hesketh JE, Campbell GP, Lobley GE, Maltin CA, Acamovic F, Palmer RM. Stimulation of actin and myosin synthesis in rat gastrocnemius muscle by clenbuterol; evidence for translational control. Comp Biochem Physiol 1992;102C:23-27.
18. Hinkle RT, Hodge KMB, Cody DB, Sheldon RJ, Kobilka BK, Isfort R. Skeletal muscle hypertrophy and anti-hypertrophic effects of clenbuterol are mediated by the beta2-adrenergic receptor. Muscle Nerve 2002;25:729-734.
19. Ingalls CP, Barnes WS, Smith SB. Interaction between clenbuterol and run training: effects on exercise performance and MLC isoform content. J Appl Physiol 1996;80:795-801.
20. Jenson J, Brors O, Dahl HA. Different beta-adrenergic receptor density in different rat skeletal fibre types. Pharmacol Toxicol 1995;76:380-385.
21. Kearns CF, McKeever KH. Clenbuterol diminishes aerobic performance in horses. Med Sei Sports Exerc 2002;34:1976-1985.
22. Lynch GS, Hayes A, Campbell SP, Williams DA. Effects of beta2-agonist administration and exercise on contractile activation of skeletal muscle fibres. J Appl Physiol 1996;81:1610-1618.
23. MacLennan PA, Edwards RHT. Effects of clenbuterol and propranolol on muscle mass: evidence that clenbuterol stimulates muscle beta-adrenoceptors to induce hypertrophy. Biochem J 1989;264:573-579.
24. Maltin CA, Delday MI, Hay SM, Baillie AG. Denervation increases clenbuterol sensitivity in muscle from young rats. Muscle Nerve 1992;15:188-192.
25. Maltin CA, Hay SM, Delday MI, Lobley GE, Reeds JP. The action of the beta-agonist clenbuterol on protein metabolism in innervated and denervated phasic muscles. Biochem J 1989;261:965-971.
26. +2-dependent proteolysis in rat skeletal muscle through beta2-adrenoceptors and cAMP. Am J Physiol 2001;281:E449-E454.
27. Navegantes C, Resano NM, Baviera AM, Migliorini RH, Kettelhut IC. Effect of sympathetic denervation on the rate of protein synthesis in rat skeletal muscle. Am J Physiol Endocrinol Metab 2004;286:E642-647.
28. Ng Y, Goldspink DF, Burniston JG, Clark WA, Colyer J, Tan L-B. Characterisation of isoprenaline myotoxicity on slow-twitch versus cardiac muscle. Int J Cardiol 2002;86:299-309,
29. Patiyal SN, Katoch S. Tissue specific and variable collagen proliferation in Swiss albino mice treated with clenbuterol. Physiol Res (in press).
30. Petrou M, Wynne DG, Boheler KR, Yacoub MH. Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes. Circulation 1995;92:483-489.
31. Rajab PJF, Riaz S, Tomlinson D, Ball D, Greenhaff PL. Skeletal muscle myosin heavy chain isoforms and energy metabolism after clenbuterol treatment in the rat. Am J Physiol 2000;279:R1076-R1081.
32. Rothwell NJ, Stock MJ. Effect of a selective beta2-adrenergic agonist (clenbuterol) on energy balance and body composition in normal and protein deficient rats. Biosci Rep 1987;7:933-940.
33. Ryall JG, Plant DR, Gregorevic P, Sillence MN, Lynch GS. Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats. J Physiol (Lond) 2004;555:175-188.
34. Sleeper MM, Kearns CF, McKeever KH. Chronic clenbuterol administration negatively alters cardiac function. Med Sci Sports Exerc 2002;34:643-650.
35. Soma LR, Uboh CE, Guan F, Luo Y, Teleis D, Runbo L, et al. Tissue distribution of clenbuterol in the horse. J Vet Pharmacol Therap 2004;27:91-98.
36. Sweet F, Puchtler H, Rosenthal SI. Sirius red F3BA as a stain for connective tissue. Arch Pathol 1964;78:69-72.
37. Tan L-B, Burniston JG, Clark WA, Ng Y, Goldspink DF. Characterisation of adrenoceptor involvement in skeletal and cardiac myotoxicity induced by sympathomimetic agents: towards a new bioassay for beta-blockers. J Cardiovasc Pharmacol 2003;41:518-525.
38. Von Deutsch DA, Abukhalaf IK, Wineski LE, Aboul-Enein HY, Pitts SA, Parks BA, et al. Beta-agonist-induced alterations in organ weights and protein content: comparison of racemic clenbuterol and its enantiomers. Chirality 2000;12:637-648.
39. Yang YT, McElligott MA. Multiple actions of beta adrenergic actions on skeletal muscle and adipose tissue. Biochem J 1989;261:1-10.
40. Yimlamai T, Dodd SL, Borst SE, Park S. Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway. J Appl Physiol 2005;91:71-80.
41. Zeman RJ, Ludemann R, Easton TG, Etlinger JD. Slow to fast alterations in skeletal muscle fibers caused by clen-buterol, a beta 2-receptor agonist. Am J Physiol 1988;254: E726-E732.